Romix Biosciences
PrivateLast Round
Pre Seed
Jul 30, 2025
Total Funding Raised
$1.34M
Company Overview
Romix Biosciences is a biotechnology company that develops an AI-enabled, full-body molecular scan platform using cell-free RNA liquid biopsy for disease profiling and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Romix Biosciences Comparables
Compare Romix Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RealSeq Biosciences | 80% | |
| Flomics Biotech | 79% | |
| GeneCentric | 77% |
Romix Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 30, 2025 | ||||
| Accelerator | Oct 29, 2024 | ||||
| Accelerator | Aug 1, 2024 |
Key People
Founding team and executive leadership
Romix Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Star Ventures | Pre Seed |
| 2048 Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2024
$120K raised in Accelerator round.
Romix Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Romix Biosciences's valuation, stock price, and market status.
Is Romix Biosciences a public or private company?
Romix Biosciences is a private company.
What is the current stock price of Romix Biosciences?
Romix Biosciences is a private company, so its shares have no public market price. Caplight tracks Romix Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Romix Biosciences worth (valuation)?
Valuation information for Romix Biosciences is not publicly available.
Can I buy Romix Biosciences stock?
Romix Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Romix Biosciences's last funding round?
Romix Biosciences's most recent funding round was Pre Seed on July 30, 2025.
Who are the main investors in Romix Biosciences?
Key investors in Romix Biosciences include First Star Ventures, 2048 Ventures.
Will Romix Biosciences IPO soon?
No public IPO plans have been announced for Romix Biosciences.
How can I track Romix Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Romix Biosciences's shares on secondary markets.